Intellectual Property Cases
Cases 11 - 20 of 190
NEXUS PHARMACEUTICALS, INC. v. NEVAKAR, INC. et al We have downloadable decisions or orders for this case
as 1:2022cv05683
Plaintiff: NEXUS PHARMACEUTICALS, INC.
Defendant: NEVAKAR, INC., NEVAKAR INJECTABLES, INC., PAR STERILE PRODUCTS, LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PAR PHARMACEUTICAL, INC. et al v. CIPLA LIMITED et al
as 3:2022cv02814
Plaintiff: PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC and ENDO PAR INNOVATION COMPANY, LLC
Defendant: CIPLA LIMITED and CIPLA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PAR PHARMACEUTICAL, INC. et al v. CIPLA LIMITED et al
as 2:2022cv02814
Plaintiff: PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC and ENDO PAR INNOVATION COMPANY, LLC
Counter Claimant: CIPLA LIMITED
Defendant: CIPLA USA, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PAR PHARMACEUTICAL, INC. et al v. AMNEAL EU, LIMITED et al
as 3:2020cv18322
Defendant: AMNEAL PHARMACEUTICALS OF NEW YORK, LLC, AMNEAL BIOSCIENCES LLC, AMNEAL EU, LIMITED and others
Plaintiff: PAR PHARMACEUTICAL, INC., PAR STERILE PRODUCTS, LLC and ENDO PAR INNOVATION COMPANY, LLC
Cause Of Action: 35 U.S.C. § 271
PAR PHARMACEUTICAL, INC. et al v. EAGLE PHARMACEUTICALS, INC.
as 3:2020cv18319
Defendant: EAGLE PHARMACEUTICALS, INC.
Plaintiff: PAR STERILE PRODUCTS, LLC, PAR PHARMACEUTICAL, INC. and ENDO PAR INNOVATION COMPANY, LLC
Cause Of Action: 35 U.S.C. § 271
PAR PHARMACEUTICAL, INC. et al v. DR. REDDY'S LABORATORIES, INC et al
as 3:2020cv18328
Defendant: DR. REDDY'S LABORATORIES, LTD. and DR. REDDY'S LABORATORIES, INC
Plaintiff: PAR STERILE PRODUCTS, LLC, PAR PHARMACEUTICAL, INC. and ENDO PAR INNOVATION COMPANY, LLC
Cause Of Action: 35 U.S.C. § 271
PAR PHARMACEUTICAL, INC. et al v. AUROBINDO PHARMA U.S.A., INC. et al
as 3:2020cv18334
Defendant: AUROBINDO PHARMA U.S.A., INC. and AUROBINDO PHARMA LIMITED
Plaintiff: PAR STERILE PRODUCTS, LLC, PAR PHARMACEUTICAL, INC. and ENDO PAR INNOVATION COMPANY, LLC
Cause Of Action: 35 U.S.C. § 271
Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc. We have downloadable decisions or orders for this case
as 1:2019cv02216
Defendant: Mylan Pharmaceuticals Inc.
Plaintiff: Takeda Pharmaceuticals U.S.A., Inc.
3Rd Party Defendant: Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.
Intervenor: Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical, Inc. et al v. Fresenius Kabi USA, LLC
as 1:2019cv01985
Plaintiff: Par Sterile Products, LLC, Par Pharmaceutical, Inc. and Endo Par Innovation Company, LLC
Defendant: Fresenius Kabi USA, LLC
Cause Of Action: 35 U.S.C. § 271
Par Pharmaceutical, Inc. et al v. American Regent, Inc.
as 1:2019cv01490
Defendant: American Regent, Inc.
Plaintiff: Par Sterile Products, LLC, Par Pharmaceutical, Inc. and Endo Par Innovation Company, LLC
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?